Health Indicators

INDICATOR	YEAR	UNIT	VALUE
ُEstimated population (Lebanese)	2017	1000 citizens	4,421
Total area		Km²	10,452
Population growth rate	2017		1.5
Life expectancy	2012	Years	81.24
Population <15	2017	Percent	24.6
Population > 65	2017	Percent	9.7
Total GDP	2017	Billion US$	53.4
GDP per Capita	2017	US $	12,078
THE per Capita	2015	US $	863
THE % GDP	2015	Percent	7.41
OOP % THE	2015	Percent	32.7
Physicians	2017	Per 10 000 population	31.3
Nurses	2017	Per 10 000 population	34
Midwives	2017	Per 10 000 population	2.4
Dentists	2017	Per 10 000 population	15.2
Beds	2016	Per 10 000 population	27.3

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C01EB17	BRAVIGO	G	Ivabradine (HCl) - 5mg	5mg	Tablet, film coated	1,237,679 L.L
C01EB17	BRADIREM	G	Ivabradine (HCl) - 7.5mg	7.5mg	Tablet, film coated	1,134,203 L.L
C01EB17	BRAVIGO	G	Ivabradine (HCl) - 7.5mg	7.5mg	Tablet, film coated	1,237,679 L.L
D07AC01	BETASONE	G	Betamethasone (valerate) - 1mg/g	1mg/g	Cream	120,306 L.L
M03BX01	BACLOCALM	G	Baclofen - 25mg	25mg	Tablet	928,595 L.L
M03BX01	BACLOCALM	G	Baclofen - 10mg	10mg	Tablet	589,947 L.L
S01EA05	BGLAU	G	Brimonidine tartrate - 0.2%	0.2%	Drops solution	638,325 L.L
C02KX01	BOSENTAN ARROW	G	Bosentan (monohydrate) - 125mg	125mg	Tablet, film coated	51,483,159 L.L
S01EA05	BRIMO	G	Brimonidine tartrate - 0.2%	0.2%	Drops solution	658,483 L.L
S01EA05	BRIMOGAN	G	Brimonidine tartrate - 0.2% w/v	0.2% w/v	Drops solution	483,783 L.L
S01EA05	BRIMONIDINE BIOGARAN	G	Brimonidine tartrate - 2mg/ml	0.2%	Drops solution	412,560 L.L
C02KX01	BOSENTAN ARROW	G	Bosentan (monohydrate) - 62.5mg	62.5mg	Tablet, film coated	51,483,159 L.L
L01XG01	BORCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	11,020,381 L.L
L01XG01	BORCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	11,020,381 L.L
L01XG01	BORTEZOMIB ACCORD	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	13,007,658 L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	14,169,600 L.L
L01XG01	BORTEZOMIB PHARMINICIO	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	13,007,658 L.L
L01XG01	BORTEZOMIB SHILPA	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	9,902,420 L.L
L01XG01	BORTEZOMIB SPC	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	15,743,401 L.L
C03CA01	BIOLASOMIDE	G	Furosemide - 40mg	40mg	Tablet	181,419 L.L
D07CC01	BETAFUCIN	G	Fusidic acid - 20mg/g, Betamethasone valerate - 1mg/1g		Cream	210,983 L.L
D07CC01	BETASONE-N	G	Neomycin (sulfate) - 3.5mg/g, Betamethasone (valerate) - 1mg/g		Cream	398,033 L.L
L01DC01	BLEO-CELL	G	Bleomycin (sulfate) - 15mg	15mg	Injectable powder for solution	3,817,857 L.L
A11A	BEBE-VIT	G	Vitamin A - 1500IU/ml, Vitamin D3 - 400IU/ml, Vitamin E - 5mg/ml, Vitamin C - 40mg/ml, Vitamin B1 - 0.5mg/ml, Vitamin B2 - 0.6mg/ml, Vitamin B6 - 0.6mg/ml, Nicotinamide - 8mg/ml		Drops	287,582 L.L
L03AX03	BCG-MEDAC	G	BCG seed RIVM derived from seed 1173-P2 - 2x10? to 3x10? viable units		Injectable powder for suspension+diluent	L.L
D07XC01	BETA-MICOTER	G	Betamethasone (dipropionate) - 0.5mg/g, Clotrimazole - 10mg/g		Cream	415,951 L.L
J01CR02	BETAMOX ES	G	Amoxicillin - 600mg/5ml, Clavulanic Acid - 42.9mg/5ml		Powder for suspension	592,635 L.L
M05BA06	BONAFOR	G	Ibandronic acid (monosodium monohydrate) - 150mg	150mg	Tablet, film coated	383,955 L.L
N07BC01	BUPENSAN	G	Buprenorphine - 8mg	8mg	Tablet	1,259,180 L.L
N07BC01	BUPRENORPHINE ARROW	G	Buprenorphine - 8mg	8mg	Tablet	1,115,389 L.L